Recently, the utility of this technology to target tumor cells has been shown using ligand conjugates consisting of either a bivalent small-molecule or a ligand-dye conjugate specific for CA IX linked to maytansinoid DM1 (a potent cytotoxic agent) via cleavable disulfide bonds [90,93]. This evidence concerns the gene CA9 and neoplasm.